Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

º¹¸·Åõ¼® ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ÈÄõ¼º õ°ø¼º ÇǺκ´ÀÇ ¼º°øÀû Ä¡·á 1¿¹ Successful Treatment of Acquired Perforating Dermatosis in a Peritoneal Dialysis Patient Using Oral Isotretinoin

´ëÇѳ»°úÇÐȸÁö 2020³â 95±Ç 3È£ p.201 ~ 204
±èÈñ¼­, ÀÌ»óÈñ, À̹ÌÁö, Áֹμ÷, À̵¿¿µ, ¹®°æÇù, ±è¹ü,
¼Ò¼Ó »ó¼¼Á¤º¸
±èÈñ¼­ ( Kim Hui-Seo ) 
Gwangmyeong Sungae Hospital Department of Internal Medicine

ÀÌ»óÈñ ( Lee Sang-Hee ) 
Veterans Health Service Medical Center Department of Internal Medicine
À̹ÌÁö ( Lee Mi-Ji ) 
Veterans Healthcare System Medical Center Department of Pathology
Áֹμ÷ ( Jue Mihn-Sook ) 
Veterans Health Service Medical Center Department of Dermatology
À̵¿¿µ ( Lee Dong-Young ) 
Veterans Health Service Medical Center Department of Internal Medicine
¹®°æÇù ( Moon Kyoung-Hyub ) 
Veterans Health Service Medical Center Department of Internal Medicine
±è¹ü ( Kim Beom ) 
Veterans Health Service Medical Center Department of Internal Medicine

Abstract


Acquired perforating dermatosis (APD) triggers severe itching, and is observed most often in patients with diabetes mellitus (DM) and chronic kidney disease (CKD). Various treatments, such as topical steroids, topical and oral retinoids, allopurinol, and ultraviolet B (UVB) phototherapy, have been used. However, as the precise etiology is unknown, there are a lack of well-established treatment guidelines. We report a peritoneal dialysis patient with a diagnosis of APD who was resistant to topical steroids, phototherapy, allopurinol, and topical retinoids. Severe pruritus persisted, which compromised his ability to lead a normal life. As a final treatment option, we used oral isotretinoin and the patient experienced a dramatic improvement.

Å°¿öµå

Chronic kidney disease peritoneal dialysis; Isotretinoin; Pruritus

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS